Retrospective study of the associations between hepatitis C virus infection and metabolic factors

Table 3 Unadjusted logistic regression analysis of the association between baseline metabolic components and antiviral treatment response (n = 115)

Variables	Crude OR	95%CI (P value)
BMI > 30 kg/m2	0.825	0.303-2.243 (0.706)
IFG (> 100 mg/dL)	0.609	0.266-1.393 (0.140)
T2DM (diagnosis, fasting blood glucose > 126 mg/dL, or use of anti-diabetic drugs)	1.094	0.301-3.975 (0.892)
High blood pressure (> 16/10.66 kPa)	0.713	0.269-1.889 (0.495)
High triglycerides	1.075	0.338-2.978 (0.889)
High cholesterol and low HDL levels	0.782	0.367-1.666 (0.523)
Presence of any metabolic syndrome components (high cholesterol levels, hyperlipidemia, high BP, or BMI > 30), without T2DM	0.448	0.551-1.301 (0.847)
Metabolic syndrome	0.597	0.141-2.520 (0.483)

The non-responder group is the reference group. OR: Odds ratio; BMI: Body mass index; IFG: Impaired fasting glucose; T2DM: Type 2 diabetes mellitus; HDL: High-density lipoprotein cholesterol; BP: Blood pressure.